This Webinar was held the 28 January 2025.
Explore the latest insights on hemochromatosis (HC), the most common inherited disorder among Caucasians. This webinar covers genetic insights, clinical manifestations, and the 2022 EASL guidelines, highlighting non-invasive diagnostic tools like MRI and the role of genetic testing. Learn about disease staging, treatment strategies, and patient management to prevent complications.
Speakers |
|
 |
Heinz Zoller is a Professor of Hepatoloy at the Medical University of Innsbruck, Austria. As physician scientist he is senior consultant at the University Hospital, where he cares for patients with liver diseases and has a particular focus on pre- and post-livertransplant patients. Heinz Zoller studied and trained in Austria and Cambridge, UK before he was appointed in Innsbruck. His main research interest is iron metabolism which led to numerous publications on hemochromatosis and rare iron disorders. The EASL clinical practice guidelines on hemochromatosis and the Biorion update on hemochromatosis classification and nomenclature are among his recent contributions to the field, where he is aiming to translate basic science into improved patient care. |
 |
Elena Corradini is an Associate Professor of Internal Medicine at the University of Modena and Reggio Emilia, Italy. She is an internal medicine specialist and practices inpatient and outpatient clinics at the Internal Medicine Unit and the Centre for Hemochromatosis and Hereditary Liver Diseases at the University Hospital of Modena, where she is in charge of the Hemochromatosis and Hereditary Liver Diseases Outpatient Clinic and the Laboratory of Molecular Genetics. She is also a member of the Laboratory of Iron Metabolism team led by Prof. Antonello Pietrangelo. Her basic and clinical research activities focus primarily on iron metabolism and iron-related disorders, including genetic and acquired liver diseases with altered iron homeostasis, as well as complex internal medicine diseases. She was also a panel member of the 2022 EASL Clinical Practice Guidelines on Haemochromatosis. |
 |
Antonello Pietrangelo, M.D., Ph.D., is the Director of the Internal Medicine Unit and the Center for Hemochromatosis and Rare Liver Diseases at the University Hospital of Modena, Italy. He has dedicated his professional and scientific career to the study of liver diseases, particularly focusing on rare liver disorders. Prof. Pietrangelo is the founder and first president of the International Society for the Study of Iron in Biology and Medicine (BioIron). He has also served as a member of the Scientific Committee and as chair of the Ethics Committee of the European Association for the Study of the Liver (EASL). Currently, he is the national coordinator of the Spoke unit for “Genetic Diseases” under the National Center for Gene Therapy and Drugs Based on RNA Technology, funded by the EU. He coordinates the ERN RARE-LIVER working group on Hemochromatosis and Rare Hepatic Iron-Loading Diseases (HILD). |
Log in to post comments